ArticleOxford medical case reports2026
Acute promyelocytic leukaemia presenting with gingival hypertrophy: an atypical oral presentation.
Article in Oxford medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute promyelocytic leukaemia (APL) is a subtype of acute myeloid leukaemia characterised by the PML-RARα fusion gene and a high risk of early mortality if treatment is delayed. Gingival hypertrophy is an uncommon manifestation of APL and is more typically associated with monocytic and myelomonocytic AML. We report a 26-year-old male who presented with a three-week history of progressive gingival enlargement, initially managed as gingivitis for two weeks, resulting in delayed haematological evaluation. Microgranular APL was confirmed by bone marrow morphology and fluorescence in situ hybridisation, demonstrating t(15;17). Although pancytopenia was present, the absence of hyperleukocytosis or overt coagulopathy contributed to an atypical clinical picture. Due to resource constraints, all-trans retinoic acid-based therapy was unavailable, and induction chemotherapy was administered, with a fatal outcome after one week. This case highlights gingival hypertrophy as an atypical early presentation and the impact of delayed diagnosis and limited access to essential therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.